FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34814811000001105: Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105539201000001119 Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105539301000001111 Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Is a Ribociclib 200mg tablets 63 tablet true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has AMP Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ribociclib succinate true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ribociclib true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start